0001214659-23-000809.txt : 20230119 0001214659-23-000809.hdr.sgml : 20230119 20230119094536 ACCESSION NUMBER: 0001214659-23-000809 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230117 FILED AS OF DATE: 20230119 DATE AS OF CHANGE: 20230119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Christensen Jamie CENTRAL INDEX KEY: 0001599324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 23536135 MAIL ADDRESS: STREET 1: C/O MIRATI THERAPEUTICS, INC. STREET 2: 9393 TOWNE CENTRE DRIVE, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 3545 CRAY COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-58207.xml PRIMARY DOCUMENT X0306 4 2023-01-17 0001576263 Mirati Therapeutics, Inc. MRTX 0001599324 Christensen Jamie C/O MIRATI THERAPEUTICS 3545 CRAY COURT SAN DIEGO CA 92121 false true false false EVP, Chief Scientific Officer Common Stock 2023-01-17 4 S false 1358 42.3778 D 98765 D Common Stock 2023-01-17 4 S false 887 42.3821 D 97878 D Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022. Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021. /s/ Reena Desai, Attorney-in-Fact 2023-01-18